Ipca Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)
Ipca Laboratories Ltd · Outcome · 05 Nov 2026, 7:15 pm
Ipca Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 2,910 (+13.8% YoY | +4.4% QoQ) ■ EBITDA: 673 (+23.6% YoY | +0.6% QoQ) ■ EBITDA Margin (%): 23.1 (+183 bps YoY | -87 bps QoQ) ■ PAT: 375 (+32.8% YoY | -6.7% QoQ) ■ EPS (INR): 15.3 (+23.8% YoY | -3.5% QoQ)
Original exchange filing (PDF)
More announcements from Ipca Laboratories Ltd
- Transcript of Conference Call held on 05.11.2026 · 06 Nov 2026
- Audio Link of Conference Call held on 05.11.2026 · 05 Nov 2026
- Standalone and Consolidated Financial Results for second quarter and half year ended 30.09.2026 · 05 Nov 2026
- Schedule of Conference Call · 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 05 Nov 2026
- Ipca Laboratories Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 05 Nov 2026
- Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Standalone and Consolidated .... · 05 Nov 2026
- Transcript of Conference Call · 17 Aug 2026
